Date Filer Title Filing Type Shares Traded Price Total Held
Sep 11, 2024
Chaubey Alka
Chief Medical Officer
Trans History: 15
 Chief Medical Officer Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,075 $0.48 45,323
Sep 11, 2024
OLDAKOWSKI MARK
Chief Operating Officer
Trans History: 22
 Chief Operating Officer Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,568 $0.48 61,283
Jun 18, 2024
BARKER DAVID L
Director
Trans History: 19
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Linney Yvonne
Director
Trans History: 12
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Luderer Albert
Director
Trans History: 12
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Mamuszka Hannah
Director
Trans History: 10
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Rajkovic Aleksandar
Director
Trans History: 4
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
TWOMEY CHRISTOPHER J
Director
Trans History: 15
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Vuori Kristiina MD
Director
Trans History: 9
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000
Jun 18, 2024
Wong Vincent Jung-Fai
Director
Trans History: 3
 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 30,000 -- 30,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.